Geopolitical risk is emerging as one of the greatest challenges facing domestic and international business today. It has risen from a boardroom ...

Wildfire risk management is becoming an increasingly critical priority for electric utilities as they seek to safeguard communities, protect infrastructure and maintain uninterrupted service. The ...

CEO of Schwenk AG & Crisis Control Solutions LLC, a leading expert in risk and crisis management for the automotive industry. In an era where disruption is the new normal, supply chain resilience has ...

As the frequency and scale of ocean racing events continues to grow, the Marine Mammal Advisory Group (MMAG) is supporting all stakeholders in conservation efforts and risk mitigation concerning ...

The increasing volume of litigation involving Poly- and Perfluoroalkyl Substances (PFAS) presents substantial financial and operational uncertainties for the insurance sector. Due to their ...

The traditional approach to risk mitigation is to assess and prioritize risks and then tackle each, starting from the top. For cybersecurity risk, that often includes tactics such as employee training ...

I want to empower Investors, to make as much money, from both income and capital appreciation, with as little risk as possible, through my coverage of dividend, growth, and value companies. This broad ...

A panel discussion covers considerations within REMS programs aimed at minimizing risks associated with bispecific therapy. NOTE: Not all FDA-approved bispecific antibodies are associated with a REMS ...

The property insurance market has reached a point of stabilization after years of volatile rate hikes and financial losses. However, external threats — especially those posed by natural disasters — ...

Many countries in the Middle East and North Africa (MENA region) are affected by extreme weather events. Heavy rainfall has ...

Q3 2025 Management View CEO James Williamson outlined two significant strategic actions: "First, we are exiting global retail ...

Vandetanib (Caprelsa, Sanofi), a thyroid cancer medication, is an oral tyrosine kinase inhibitor that targets cell receptors involved in RET, VEGFR and EGFR signaling. The FDA has removed the Risk ...